In the TME, altering Treg function by inducing Treg fragility, with lower expression of FOXP3, enhanced production of tumor-killing cytokines such as interferon-gamma (IFNγ), could contribute to the anti-tumor therapy4. This evidence concerns the gene IFNG and neoplasm.